This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stöllberger, C.
Right arrow Articles by Finsterer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stöllberger, C.
Right arrow Articles by Finsterer, J.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2001, p. 997-1002, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.997-1002.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Seroprevalence of Antibodies to Microorganisms Known To Cause Arterial and Myocardial Damage in Patients with or without Coronary Stenosis

C. Stöllberger,1,* G. Mölzer,1 and J. Finsterer2

Medizinische Abteilung der Krankenanstalt Rudolfstiftung, A-1030 Vienna,1 and Neurologisches Krankenhaus Rosenhügel und Ludwig Boltzmann Institut für Epilepsie and neuromuskuläre Erkrankungen, A-1130 Vienna,2 Austria

Received 29 May 2001/Returned for modification 28 June 2001/Accepted 16 July 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Infections are assumed to play a role in coronary artery disease (CAD) and cardiomyopathies. It is unknown whether the seroprevalence of antibodies to these microorganisms is higher in patients with than without CAD. The seroprevalence of antibodies to Bartonella henselae, Borrelia burgdorferi, Chlamydia pneumoniae, Coxiella burnetii, Helicobacter pylori, human granulocytic Ehrlichia, Leptospira, Rickettsia conorii, and Treponema pallidum was assessed prospectively in patients with exertional dyspnea or anginal chest pain who underwent coronary angiography because of suspected CAD. Patients with normal angiograms (NA) were those in whom no more than 50% stenosis of any coronary artery was found. Patients with CAD were patients who underwent percutaneous transluminal coronary angioplasty. There were 50 patients with CAD (9 female) and 62 with NA (25 female), with a mean age of 62 years. All patients had antibodies to at least one microorganism: to B. henselae, 8% of CAD patients and 5% of NA patients; to B. burgdorferi IgG, 14% CAD and 6% NA; to B. burgdorferi IgM, 6% CAD and 3% NA; to C. pneumoniae lipopolysaccharide (LPS) IgA, 76% CAD and 77% NA; to C. pneumoniae LPS IgG, 80% CAD and 90% NA; to C. burnetii, 0% CAD and 5% NA; to H. pylori, 92% CAD and 68% NA; to human granulocytic Ehrlichia, 8% CAD and 3% NA; to Leptospira IgG, 4% CAD and 2% NA; to R. conorii, 10% in both groups; and to T. pallidum, 2% CAD and 0% NA. The seroprevalence of antibodies to micro-organisms known to induce arterial and myocardial damage does not differ between patients with CAD and NA.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Infections are assumed to play a role in the pathogenesis of coronary artery disease (CAD) and cardiomyopathies. Among microorganisms known to cause arterial and myocardial damage are Bartonella henselae, Borrelia burgdorferi, Chlamydia pneumoniae, Coxiella burnetii, Helicobacter pylori, human granulocytic Ehrlichia, Leptospira, Rickettsia conorii, and Treponema pallidum (4, 8, 13, 14, 16, 26, 27, 28). It is unknown, however, whether the seroprevalence of antibodies to these microorganisms is higher in patients with coronary heart disease than in those without coronary heart disease who suffer from exertional dyspnea or anginal chest pain. Therefore, a prospective study was carried out with patients with exertional dyspnea or anginal chest pain who underwent a coronary angiography because of suspected coronary heart disease based on pathologic findings on stress test, scintigraphy, and echocardiography. Aims of the study were (i) to compare the seroprevalence of specific antibodies to microorganisms known to cause arterial and myocardial damage between patients with normal angiograms and patients with coronary heart disease and (ii) to assess the seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with normal angiograms with regard to (a) possible causes of exertional dyspnoea and anginal chest pain, like arterial hypertension, hemochromatosis, hypothyroidism, hypoparathyroidism, tachycardiomyopathy, amyloidosis, and neuromuscular disorders, and (b) echocardiographic findings (17).


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Patients. The group of patients with normal angiograms consisted of consecutive patients in whom a coronary angiography had been performed because coronary heart disease was suspected by clinical findings (exertional dyspnea or anginal chest pain) and noninvasive tests (stress test, scintigraphy, and echocardiography) and no relevant (>50%) stenosis of any coronary artery had been found. Excluded were patients in whom a coronary angiography was performed prior to valve surgery or organ transplantation. The group of patients with coronary heart disease consisted of consecutive patients who underwent percutaneous transluminal coronary angioplasty (PTCA) of one or more coronary artery stenosis. The coronary angiographies and PTCA were performed at the 2nd Medical Department of the Krankenanstalt Rudolfstiftung. All patients of both groups were invited for a follow-up visit between April and July 1999. During this visit, patients with normal coronary angiograms underwent extensive investigations, including a medical history, physical examination, 12-lead electrocardiogram (ECG), transthoracic 2-D, M-mode and Doppler echocardiography, and blood tests (blood sedimentation rate, red and white blood cell counts, thrombocyte count, transferrin saturation, creatine kinase, gamma -glutamyl-transpeptidase, calcium, potassium, thyroid stimulating hormone, and analysis of the hemochromatosis gene mutations C282Y and H63D). Based on these investigations, possible causes of dyspnea and anginal chest pain were assessed according to predefined criteria (Table 1) (17). Patients with coronary heart disease underwent clinical examination and exercise testing 3 months after PTCA. At this visit, blood was taken from both groups for serologic investigations comprising specific antibodies to the following microorganisms, which are known to cause arterial and myocardial damage: B. henselae, B. burgdorferi, C. pneumoniae, C. burnetii, H. pylori, human granulocytic Ehrlichia, Leptospira, R. conorii, and T. pallidum. The test systems used are listed on Table 2. All tests were performed according to the manufacturer's instructions at one institute (Klinisches Institut für Hygiene der Universität Wien). Informed consent was obtained from all patients, and the study was approved by the institutional ethics committee.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Diagnostic criteria for possible causes of symptoms and their prevalence in group of patients with normal angiograms


                              
View this table:
[in this window]
[in a new window]
 
TABLE 2.   Test systems used in order to identify specific antibodies to selected pathogens in sera of patients with cardiac symptomsa


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Included in the study were 112 patients, 50 with coronary heart disease who underwent PTCA between January and April 1999 and 62 with normal coronary angiograms performed between January and December 1998. The group with coronary heart disease consisted of 9 female and 41 male patients with a mean age of 62 years. In the group with normal coronary angiograms (25 female, 37 male, mean age of 62 years), the patients suffered from anginal chest pain (n = 38 [61%]), exertional dyspnea (n = 12 [19%]), or a combination of exertional dyspnea and anginal chest pain (n = 12 [19%]). In this group, all patients except one underwent one or more noninvasive tests prior to coronary angiography: echocardiography (n = 25), bicycle stress test (n = 3), echocardiography and bicycle stress test (n = 14), echocardiography and scintigraphy (n = 6), bicycle test and scintigraphy (n = 1), or echocardiography, bicycle test, and scintigraphy (n = 12). In patients with normal coronary angiograms, 47 patients had smooth normal vessels and 15 patients had coronary sclerosis but no significant (>50%) stenosis. In 48 of the 62 patients with normal coronary angiograms, one or more causes of cardiac symptoms could be assessed: arterial hypertension (n = 44), hemochromatosis (n = 2), hypothyroidism (n = 3), tachycardiomyopathy (n = 5), and neuromuscular disorder (n = 7). In the remaining 14 patients with normal coronary angiograms, the cause of exertional dyspnea and anginal chest pain remained unknown (Table 1) (17). The seroprevalence of antibodies known to cause arterial and myocardial damage is listed on Table 3. All included patients had antibodies to at least one microorganism. The seroprevalence was similarly distributed between patients with coronary artery stenosis and with normal coronary angiograms. Antibodies to C. pneumoniae and H. pylori were most prevalent in both groups.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 3.   Seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage in patients with exertional dyspnea with coronary heart disease and with normal coronary angiogramsa

In the group with coronary heart disease, five patients had antibodies only to H. pylori, and four patients had only C. pneumoniae IgG and IgA. Antibodies to two different microorganisms were found in 25 patients, most commonly a combination of antibodies to H. pylori and C. pneumoniae IgG and IgA (n = 19). Antibodies to three microorganisms were found in nine patients, to four microorganisms in five patients, and to five microorganisms in two patients.

In the group with normal coronary angiograms, 3 patients had antibodies only to H. pylori and 14 patients had antibodies only to C. pneumoniae IgG and IgA. Antibodies to two different microorganisms were found in 35 patients, most commonly a combination of antibodies to H. pylori and to C. pneumoniae IgG and IgA (n = 21). Antibodies to three microorganisms were found in seven patients and to four microorganisms in three patients. The seroprevalence of antibodies in the group with normal coronary angiograms with regard to the possible causes of their symptoms and echocardiographic findings are listed on Tables 4 and 5. Within the group with normal coronary angiograms, the seroprevalence did not differ between patients with smooth normal vessels and patients with coronary sclerosis (data not shown).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 4.   Antibodies to microorganisms known to cause arterial and myocardial damage, possible causes for cardiac symptoms, and echocardiographic findings in 48 patients with normal coronary angiogramsa


                              
View this table:
[in this window]
[in a new window]
 
TABLE 5.   Antibodies to microorganisms known to cause arterial and myocardial damage and echocardiographic findings for 14 patients with normal coronary angiograms with no possible causes for cardiac symptoms


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

This study shows that the seroprevalence of microorganisms known to induce arterial and myocardial damage is similar in patients with exertional dyspnea and anginal chest pain, irrespective if they have normal coronary angiograms or coronary heart disease. In patients with normal angiograms, the seroprevalence of antibodies to microorganisms known to cause arterial and myocardial damage does not differ with regard to (i) possible causes of exertional dyspnea and anginal chest pain, like arterial hypertension, hemochromatosis, hypothyroidism, tachycardiomyopathy, and neuromuscular disorders, and (ii) echocardiographic findings.

An association of coronary heart disease and infections with C. pneumoniae, an important respiratory pathogen, has been initially found by seroepidemiologic studies (23). More recently, the presence of C. pneumoniae in atheromatous plaques has been shown (3). At present, controversial results are available about the role of C. pneumoniae in the development of coronary heart disease. Several authors found an association (18, 24) whereas others did not (5, 6). Another microorganism suspected to play a role in coronary artherosclerosis is H. pylori, the main etiological factor in gastritis and peptic ulcer disease. H. pylori infection is postulated to have an effect on clotting mechanisms and lead to a prothrombotic state (10). Again, controversial results are available about the role of H. pylori in the development of coronary heart disease. Several authors found an association (20), whereas others did not (5, 10, 18), or found an association which can be adequately explained by the much stronger association of H. pylori infection with age and social class, both of which are linked with coronary heart disease (15). Nearly all our patients with coronary stenosis (92%) had antibodies to H. pylori, whereas in the group with normal coronary angiograms, they were found in only 68% of the patients. This finding may be due to the differing proportions of male patients in the group with coronary heart disease (82%) and with normal coronary angiograms (60%). Furthermore, epidemiological studies show that the seroprevalence of antibodies to H. pylori is generally higher in men than women (15, 22). One reason for the controversial results about the association of infections with C. pneumoniae or H. pylori with coronary heart disease might be that some of the studies compared patients with coronary heart disease and asymptomatic controls (6, 18, 20, 23, 24), whereas other studies, like the present one, compared symptomatic patients with and without coronary artery stenosis (10).

In the absence of coronary heart disease, exertional dyspnea and anginal chest pain may be caused by extracardiac causes, like pulmonary, skeletal, gastrointestinal, haematological, or neurologic disorders, by vascular causes like arterial hypertension or aortic dissection, or by myocardial damage due to inflammation, fibrosis, intoxication, storage, and neuromuscular disorders leading to left ventricular dilatation, wall thickening, and impaired diastolic and systolic function. The role of microorganisms to induce myocardial damage without affecting the coronary arteries is best established for B. burgdorferi (11, 25, 26). Infection with B. burgdorferi may lead to left ventricular dilatation and systolic dysfunction and should be a differential diagnosis in patients presenting with these findings. As listed in Tables 4 and 5, all four patients with antibodies to B. burgdorferi IgG presented with left ventricular dilatation. Since no myocardial biopsy has been performed for these patients, cardiac borreliosis could not be definitively diagnosed in these patients, but it might be an explanation for their exertional dyspnea and anginal chest pain, especially in the three cases in which no other cause could be assessed (Table 5). Myocardial damage due to myocarditis, leading to heart failure and sudden cardiac death, has been described for infections with C. pneumoniae (28), Ehrlichia (8), R. conorii (16), and Coxiella (14). Cardiac involvement in leptospirosis has been described as ECG abnormalities and pericarditis (27). Myocardial damage by Bartonella and Treponema organisms has been shown in animals (1, 4, 13). Whether these microorganisms cause myocardial damage also in humans is at present unknown.

A limitation of our study is the small number of patients. Therefore, statistical valid tests about associations could not be calculated. Further limitations are the lack of a serologic follow-up and of myocardial biopsies in patients with normal coronary angiograms and serologic findings suggestive of an infection. Additionally, testing for other antibodies to microorganisms known to induce arterial damage, like cytomegalovirus, or myocardial damage, like viruses, other bacteria, fungi, and protozoa, has not been performed.

It is concluded that assessment of the seroprevalence of antibodies to microorganisms known to induce arterial and myocardial damage is not useful to clarify the etiology of exertional dyspnea or anginal chest pain in patients with normal coronary angiograms, since they are similarly distributed as in the general population and do not differ between patients with coronary artery stenosis and with normal coronary angiograms. These findings from a relatively small number of patients have to be confirmed in a larger study.


    ACKNOWLEDGMENT

We appreciate the work of Gerold Stanek, Klinisches Institut für Hygiene der Universität Wien, Vienna, Austria, who performed the serologic tests.


    FOOTNOTES

* Corresponding author. Mailing address: Steingasse 31/18, A-1030 Vienna, Austria. Phone and Fax: 43 1 713 98 70. E-mail: claudia.stoellberger{at}chello.at.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Breitschwerdt, E. B., C. E. Atkins, T. T. Brown, D. L. Kordick, and P. S. Snyder. 1999. Bartonella vinssonii subsp. berkhoffii and related members of the alpha subdivision of the Proteobacteria in dogs with cardiac arrhythmias, endocarditis, or myocarditis. J. Clin. Microbiol. 37:3618-3626[Abstract/Free Full Text].
2. Brugada, P., and E. Andries. 1993. "Tachycardiomyopathy." The most frequently unrecognized cause of heart failure? Acta Cardiol. 48:163-169.
3. Campbell, L. A., E. R. O'Brien, A. L. Cappuccio, C.-C. Kuo, S.-P. Wang, D. Stewart, D. L. Patton, P. K. Cummings, and J. T. Grayston. 1995. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J. Infect. Dis. 172:585-588[Medline].
4. Casavant, C. H., V. Wicher, and K. Wicher. 1978. Host response to Treponema pallidum infection. III. Demonstration of autoantibodies to heart in sera from infected rabbits. Int. Arch. Allergy Appl. Immunol. 56:171-178[Medline].
5. Choussat, R., G. Montalescot, J. Collet, C. Jardel, A. Ankri, A.-M. Fillet, D. Thomas, J. Raymond, J.-P. Bastard, G. Drobinski, J. Orfila, H. Agut, and D. Thomas. 2000. Effect of prior exposure to Chlamydia pneumoniae. Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction. Am. J. Cardiol. 86:379-384[CrossRef][Medline].
6. Danesh, J., P. Whincup, M. Walker, L. Lennon, A. Thomson, P. Appleby, Y.-K. Wong, M. Bernardes-Silva, and M. Ward. 2000. Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis. Br. Med. J. 321:208-213[Abstract/Free Full Text].
7. Feder, J. N., A. Gnirke, W. Thomas, Z. Tsuchihashi, D. A. Ruddy, A. Basava, F. Dormishian, R. Domingo, Jr., M. C. Ellis, A. Fullan, L. M. Hinton, N. L. Jones, B. E. Kimmel, G. S. Kronmal, P. Lauer, V. K. Lee, D. B. Loeb, F. A. Mapa, E. McClelland, N. C. Meyer, G. A. Mintier, N. Moeller, T. Moore, E. Morikang, C. E. Prass, L. Quintana, S. M. Starnes, R. C. Schatzman, K. J. Brunke, D. T. Drayna, N. J. Risch, B. R. Bacon, and R. K. Wolff. 1996. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat. Genet. 13:399-408[CrossRef][Medline].
8. Jahangir, A., C. Kolbert, W. Edwards, P. Mitchell, J. S. Dumler, and D. H. Persing. 1998. Fatal pancarditis associated with human granulocytic Ehrlichiosis in a 44-year-old man. Clin. Infect. Dis. 27:1424-1427[Medline].
9. Jerusalem, F., and S. Zierz. 1991. Muskelerkrankungen. Klinik, Therapie, Pathologie. Thieme, Stuttgart, Germany.
10. Khurshid, A., T. Fenske, T. Bajwa, K. Bourgeois, and N. Vakil. 1998. A prospective, controlled study of Helicobacter pylori seroprevalence in coronary artery disease. Am. J. Gastroenterol. 93:717-720[CrossRef][Medline].
11. Klein, J., G. Stanek, R. Bittner, R. Horvat, C. Holzinger, and D. Glogar. 1991. Lyme borreliosis as a cause of myocarditis and heart muscle disease. Eur. Heart J. 12(Suppl. D):73-75.
12. Kudoh, C., S. Tanaka, S. Marusaki, N. Takahashi, Y. Miyazaki, N. Yoshioka, M. Hayashi, K. Shimamoto, K. Kikuchi, and O. Iimura. 1992. Hypocalcemic cardiomyopathy in a patient with idiopathic hypoparathyroidism. Intern. Med. 31:561-568[Medline].
13. La Scola, B., and D. Raoult. 1999. Culture of Bartonella quintana and Bartonella henselae from human samples: a 5-year experience (1993 to 1998). J. Clin. Microbiol. 37:1899-1905[Abstract/Free Full Text].
14. Maisch, B. 1986. Rickettsial perimyocarditis---a follow-up study. Heart Vessels 2:55-59[CrossRef][Medline].
15. McDonagh, T. A., M. Woodward, C. E. Morrison, J. J. V. McMurray, H. Tunstall-Pedoe, G. D. O. Lowe, K. E. L. McColl, and H. J. Dargie. 1997. Helicobacter pylori infection and coronary heart disease in the North Glasgow MONICA population. Eur. Heart J. 18:1257-1260[Abstract/Free Full Text].
16. Milon, H., J. Pasquier, R. Loire, F. Guillermet, F. Brun, L. Descos, and V.-T. Minh. 1970. Insuffisance cardiaque aigue avec séro-agglutination positive pour Rickettsia conori. Arch. Mal. Coeur Vaiss. 63:1635-1646[Medline].
17. Mölzer, G., J. Finsterer, W. Krugluger, G. Stanek, and C. Stöllberger. 2001. Possible causes of symptoms in suspected coronary heart disease but normal angiograms. Clin. Cardiol. 24:307-312[Medline].
18. Ossewaarde, J. M., E. J. Feskens, A. De Vries, C. E. Vallinga, and D. Kromhoumessiat. 1998. Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not. Epidemiol. Infect. 120:93-99[CrossRef][Medline].
19. Phatak, P. D., R. L. Sham, R. F. Raubertas, K. Dunnigan, M. T. O'Leary, C. Braggins, and J. D. Cappuccio. 1998. Prevalence of hereditary hemochromatosis in 16 031 primary care patients. Ann. Intern. Med. 129:954-961[Abstract/Free Full Text].
20. Pieniazek, P., E. Karczewska, A. Duda, W. Tracz, M. Pasowicz, and S. J. Konturek. 1999. Association of Helicobacter pylori infection with coronary heart disease. J. Physiol. Pharmacol. 50:742-751.
21. Reisinger, J., S. W. Dubrey, and R. H. Falk. 1997. Cardiac amyloidosis. Cardiol. Rev. 5:317-325.
22. Russo, A., M. Eboli, P. Pizetti, G. Di Felice, F. Ravagnani, P. Spinelli, A.-M. Hotz, P. Notti, G. Maconi, S. Franceschi, D. Ferrari, and L. Bertario. 1999. Determinants of Helicobacter pylori seroprevalence among Italian blood donors. Eur. J. Gastroenterol. Hepatol. 11:867-873[Medline].
23. Saikku, P., K. Mattila, M. S. Nieminen, J. K. Huttunen, M. Leinonen, M.-R. Ekman, P. H. Makela, and V. Valtonen. 1988. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet ii:983-986.
24. Sessa, R., M. Di Pietro, I. Santino, M. del Piano, A. Varveri, A. Dagianti, and M. Penco. 1999. Chlamydia pneumoniae infection and atherosclerotic coronary disease. Am. Heart J. 137:1116-1119[CrossRef][Medline].
25. Sonnesyn, S. W., S. C. Diehl, R. C. Johnson, H. Kubo Spencer, and J. L. Goodman. 1995. A prospective study of the seroprevalence of Borrelia burgdorferi infection in patients with severe heart failure. Am. J. Cardiol. 76:97-100[CrossRef][Medline].
26. Stanek, G., J. Klein, R. Bittner, and D. Glogar. 1990. Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy. N. Engl. J. Med. 322:249-252[Medline].
27. Watt, G., L. P. Padre, M. Tuazon, and C. Calubaquib. 1990. Skeletal and cardiac muscle involvement in severe, late leptospirosis. J. Infect. Dis. 162:266-269[Medline].
28. Wesslen, L., C. Pahlson, G. Friman, J. Fohlman, O. Lindquist, and C. Johansson. 1992. Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a swedish elite orienteer. Lancet 340:427-428[Medline].


Clinical and Diagnostic Laboratory Immunology, September 2001, p. 997-1002, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.997-1002.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Stollberger, C., Finsterer, J. (2002). Role of Infectious and Immune Factors in Coronary and Cerebrovascular Arteriosclerosis. CVI 9: 207-215 [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stöllberger, C.
Right arrow Articles by Finsterer, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stöllberger, C.
Right arrow Articles by Finsterer, J.